about
Cyclin A2: At the crossroads of cell cycle and cell invasionEpithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compoundsFoci of cyclin A2 interact with actin and RhoA in mitosis.CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistanceIBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cellsComprehensive proteome quantification reveals NgBR as a new regulator for epithelial-mesenchymal transition of breast tumor cellsProteomics of cancer stem cells.Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2.Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitorsDiallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression.Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.Cyclin A2, a novel regulator of EMT.Cyclin A2 modulates EMT via β-catenin and phospholipase C pathways.
P2860
Q26775410-6AF4FC6A-CB67-4325-9724-84A76EE4C764Q27013565-ACEB52E8-69DC-4185-9A05-1F35D19D35D2Q27346888-C83CC4EA-77CA-40F7-A3B4-8F86DB763C4DQ28540790-87F51B44-333A-40A1-87FD-79326AC908B6Q33833425-9C79F547-83BD-4528-ACC3-97D7184C2814Q34485367-E5827545-B19F-4B32-8292-C9AC7F68F972Q35032720-FA2F780D-9380-47D6-B79E-57A7756782ABQ35071416-17F27DA1-2BA7-4D3A-A00C-5C2604A9BE76Q35971810-F2A739DD-8F5C-4387-94C4-146DBFD93869Q36188773-329D67F9-B5CB-4755-B1D6-B68EC58C3A60Q36963000-7A6C1DE0-FBC9-4AC8-A43D-1509FB12E4FDQ38592713-09D92BD4-CE68-48EC-8A0C-87F15AE833B4Q38704722-F976139C-576E-4EC5-B9E6-DFD56CEF4C42Q38856257-F413C796-51C2-481C-8C64-26383551A440Q38989914-4C79A606-258E-4FFF-A6CF-B5DD062FD855Q53219064-C8D00212-9218-4B71-893F-389998019688
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cyclin A2, Rho GTPases and EMT.
@en
Cyclin A2, Rho GTPases and EMT.
@nl
type
label
Cyclin A2, Rho GTPases and EMT.
@en
Cyclin A2, Rho GTPases and EMT.
@nl
prefLabel
Cyclin A2, Rho GTPases and EMT.
@en
Cyclin A2, Rho GTPases and EMT.
@nl
P2093
P2860
P356
P1476
Cyclin A2, Rho GTPases and EMT.
@en
P2093
Bénédicte Lemmers
Jean Marie Blanchard
Nawal Bendris
Nikola Arsic
P2860
P304
P356
10.4161/SGTP.20791
P577
2012-06-27T00:00:00Z